Sujuan BaCEO at National Foundation for Cancer Research
Dr. Ba is also the Co-Founder and CEO of AIM-HI Accelerator Fund (US) which is dedicated to provide critically needed seed funding and networks to oncology startups and help translate breakthroughs in discoveries into new effective cancer therapies and diagnosis. AIM-HI has now helped launch 12 plus oncology start-ups. In addition, Dr. Ba co-founded and serves as a founding board member of the Global Coalition for Adaptive Research (US) in 2017, the organizing body leading the global implementation of GBM AGILE, a groundbreaking adaptive clinical trial initiative designed to produce new and better treatments for GBM.
Dr. Ba led the establishment of NFCR’s annual Szent-Györgyi Prize for Progress in Cancer Research, an international prize in recognition of outstanding scientific achievement in the war against cancer. She also led the establishment of the annual AIM-HI’s Women’s Venture Competition which is focused on promoting and supporting women entrepreneurs to build their oncology startups. Dr. Ba currently serves on the Women in Science Committee of CRS (Control Release Society, US) and on the International Consulting Committee of the China National Research Center for Translational Medicine (Shanghai, China)).
Dr. Ba received her B.S. in radiochemistry from Peking University and her Ph.D. in chemistry from the University of Pennsylvania.